» Articles » PMID: 30502719

The Ins and Outs of Type I INKT Cell Development

Overview
Journal Mol Immunol
Date 2018 Dec 4
PMID 30502719
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Natural killer T (NKT) cells are innate-like lymphocytes that bridge the gap between the innate and adaptive immune responses. Like innate immune cells, they have a mature, effector phenotype that allows them to rapidly respond to threats, compared to adaptive cells. NKT cells express T cell receptors (TCRs) like conventional T cells, but instead of responding to peptide antigen presented by MHC class I or II, NKT cell TCRs recognize glycolipid antigen in the context of CD1d. NKT cells are subdivided into classes based on their TCR and antigen reactivity. This review will focus on type I iNKT cells that express a semi invariant Vα14Jα18 TCR and respond to the canonical glycolipid antigen, α-galactosylceramide. The innate-like effector functions of these cells combined with their T cell identity make their developmental path quite unique. In addition to the extrinsic factors that affect iNKT cell development such as lipid:CD1d complexes, co-stimulation, and cytokines, this review will provide a comprehensive delineation of the cell intrinsic factors that impact iNKT cell development, differentiation, and effector functions - including TCR rearrangement, survival and metabolism signaling, transcription factor expression, and gene regulation.

Citing Articles

Generation of dual-attribute iTNK cells from hPSCs for cancer immunotherapy.

Zhang Y, He Y, Dai C, Zhou Z, Miao Y, Zhao Z Cell Rep Methods. 2024; 4(9):100843.

PMID: 39216483 PMC: 11440056. DOI: 10.1016/j.crmeth.2024.100843.


invariant Natural Killer T cell therapy as a novel therapeutic approach in hematological malignancies.

Boonchalermvichian C, Yan H, Gupta B, Rubin A, Baker J, Negrin R Front Transplant. 2024; 3:1353803.

PMID: 38993780 PMC: 11235242. DOI: 10.3389/frtra.2024.1353803.


Novel lipid antigens for NKT cells in cancer.

Lee M, Webb T Front Immunol. 2023; 14:1173375.

PMID: 37908366 PMC: 10613688. DOI: 10.3389/fimmu.2023.1173375.


TGF-β Promotes the Postselection Thymic Development and Peripheral Function of IFN-γ-Producing Invariant NKT cells.

Morgan R, Frank C, Greger M, Attaway M, Sigvardsson M, Bartom E J Immunol. 2023; 211(9):1376-1384.

PMID: 37702745 PMC: 10592054. DOI: 10.4049/jimmunol.2200809.


Cytokine receptor γc effectuates the generation of proinflammatory innate CD8 T cells by non-classical MHC-I molecules.

Won H, Liman N, Park J, Park J J Autoimmun. 2023; 138:103059.

PMID: 37216869 PMC: 10330485. DOI: 10.1016/j.jaut.2023.103059.


References
1.
Sklarz T, Guan P, Gohil M, Cotton R, Ge M, Haczku A . mTORC2 regulates multiple aspects of NKT-cell development and function. Eur J Immunol. 2017; 47(3):516-526. PMC: 5656007. DOI: 10.1002/eji.201646343. View

2.
Zhang X, Gu J, Zhou L, Mi Q . TIM-4 is expressed on invariant NKT cells but dispensable for their development and function. Oncotarget. 2016; 7(44):71099-71111. PMC: 5340118. DOI: 10.18632/oncotarget.12153. View

3.
De Calisto J, Wang N, Wang G, Yigit B, Engel P, Terhorst C . SAP-Dependent and -Independent Regulation of Innate T Cell Development Involving SLAMF Receptors. Front Immunol. 2014; 5:186. PMC: 4005954. DOI: 10.3389/fimmu.2014.00186. View

4.
Egawa T, Eberl G, Taniuchi I, Benlagha K, Geissmann F, Hennighausen L . Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors. Immunity. 2005; 22(6):705-16. DOI: 10.1016/j.immuni.2005.03.011. View

5.
Canchis P, Bhan A, Landau S, Yang L, Balk S, Blumberg R . Tissue distribution of the non-polymorphic major histocompatibility complex class I-like molecule, CD1d. Immunology. 1993; 80(4):561-5. PMC: 1422252. View